GreenLight Biosciences shares are trading higher after the company announced it entered into a definitive agreement to be acquired by a group of buyers led by Fall Line Capital in an all-cash transaction valuing the company at approximately $45.5 million.
$GRNA
Biotechnology: Pharmaceutical Preparations
Health Care
GreenLight Biosciences shares are trading higher after the company announced it entered into a definitive agreement to be acquired by a group of buyers led by Fall Line Capital in an all-cash transaction valuing the company at approximately $45.5 million.